Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
AI Summary
Cellular Intelligence has entered into a significant partnership with Novo Nordisk to advance research in cell therapy for Parkinson’s disease. This collaboration highlights the growing focus on innovation in health technologies.